Arlene J. Morales

No ORCID on file · 7 papers in corpus · active 1993-1998

Study types

  • article 6
  • review 1

Condition tags

  • mesh:D004715 6
  • endometriosis 6
article 1998
Evidence for Oxidatively Modified Lipid-Protein Complexes in Endometrium and Endometriosis
Fertility and Sterility ·doi:10.1016/s0015-0282(98)00087-9
article 1998
Lysophosphatidyl Choline, a Chemotactic Factor for Monocytes/T-Lymphocytes Is Elevated in Endometriosis
The Journal of clinical endocrinology and metabolism ·doi:10.1210/jcem.83.6.4823

Inflammatory processes have been hypothesized to mediate some of the clinical sequelae associated with endometriosis. The peritoneal fluid (PF) of women with endometriosis is known to contain more inflammatory cells and their associated cyt…

article 1998
Macrophage Scavenger Receptor(s) and Oxidatively Modified Proteins in Endometriosis
Fertility and Sterility ·doi:10.1016/s0015-0282(98)00088-0
review 1996
Mifepristone: Clinical Application in General Gynecology
Clinical obstetrics and gynecology ·doi:10.1097/00003081-199606000-00018

RU-486, the first clinically available antiprogestin, has numerous gynecologic applications beyond first-trimester pregnancy termination. Long-term administration of 2 mg/day of RU-486 suppresses ovulation while maintaining serum estrogen l…

article 1995
Endometrial effects of long-term low-dose administration of RU486
Fertility and Sterility ·doi:10.1016/s0015-0282(16)57478-0
article 1994
Clinical efficacy of the antiprogesterone RU486 in the treatment of endometriosis and uterine fibroids
Human Reproduction ·doi:10.1093/humrep/9.suppl_1.116

To evaluate the long-term effects of treatment with RU486 and to test its efficacy in endometriosis, a 3-month trial was conducted to evaluate the effects of daily administration (100 mg/day or approximately 2 mg/kg/day) on the functional a…

article 1993
Regression of Uterine Leiomyomata in Response to the Antiprogesterone RU 486
·doi:10.1097/00006254-199309000-00021

Uterine leiomyomata are steroid hormone-dependent tumors that are common in reproductive-age women. Some series have found leiomyomata in up to 20 per cent of women over 30 years of age. These tumors represent the most frequent indication f…